aid: cellincells

name: Cellincells

image: https://cdn.imweb.me/upload/S20250115b6d73fecf4bc6/5c7f4a53d3ce7.png

description: CellinCells is a Korean biotechnology company focused on regenerative medicine. It develops organoid‑based therapeutics and a 3D
  Tissue Reforming Technology Platform that leverages self‑organization and human embryology principles to create advanced cell therapies for
  age‑related diseases. Founded in 2014, the firm partners with pharma and research institutions to license its pipeline and expand its AI‑driven
  drug discovery capabilities.

url: https://raw.githubusercontent.com/api-evangelist/cellincells/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-07 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-07'

modified: '2026-10-07'

tags:
- Biotechnology
- Regenerative Medicine
- Cell Therapy
- AI
- Korea

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/cellincells-hosts.yml
- type: Vendors
  url: vendors/cellincells-vendors.yml
- type: DomainSecurity
  url: security/cellincells-domain-security.yml
- type: Website
  url: https://en.cellincells.com

apis: []

x-coverage:
  state: none
  reason: no-developer-program
  method: derived
  generated: '2026-10-07'
  generator: derive-coverage.py (pre-flight evidence)
  detail: the company publishes no developer documentation host and no machine-readable contract on its own domain
  evidence:
  - url: https://en.cellincells.com
    status: 200
  - url: https://equityzen.com/company/cellincells
    status: 403
x-enrichment:
  date: '2026-10-07'
  status: enriched
  artifacts_added: 5
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local